Polymorphisms of estrogen receptors and risk of depression: Therapeutic implications

Drugs

Volumn 72, Issue 13, 2012, Pages 1725-1738

  Ryan, Joanne ^a,b,c   Ancelin, Marie Laure ^a,b  

^a Montpellier 1 University   (France)

^b UNIV MONTPELLIER   (France)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Anxiety; Depression; Estrogen receptor antagonists; Estrogen receptor alpha agonists; Estrogen receptor beta agonists; Estrogen receptor expression; Genetic polymorphism

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ANXIETY DISORDER; COCHRANE LIBRARY; CORRELATION ANALYSIS; DEPRESSION; DISEASE PREDISPOSITION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HORMONAL THERAPY; HUMAN; MAJOR DEPRESSION; MEDLINE; MOLECULAR BIOLOGY; PHARMACOGENOMICS; PSYCINFO; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SYMPTOMATOLOGY;

DEPRESSION; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; MALE; PHARMACOGENETICS; POLYMORPHISM, GENETIC; RISK; SEX CHARACTERISTICS;

EID: 84865618161     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11635960-000000000-00000     Document Type: Review

References (117)

1. Boyd JH, Weissman MM. Epidemiology of affective disorders: a reexamination and future directions. Arch Gen Psychiatry 1981 Sep; 38 (9):1039-46 (Pubitemid 11061232)
2. Bromberger JT, Kravitz HM, Wei HL, et al. History of depression and women's current health and functioning during midlife. Gen Hosp Psychiatry 2005 May-Jun; 27 (3):200-8 (Pubitemid 40692936)
3. Alonso J, Angermeyer MC, Bernert S, et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004; (420):21-7
4. Patten SB. Accumulation of major depressive episodes over time in a prospective study indicates that retrospectively assessed lifetime prevalence estimates are too low. BMC Psychiatry 2009;9:19
5. Zender R, Olshansky E. Women's mental health: depression and anxiety. Nurs Clin North Am 2009 Sep; 44 (3):355-64
6. Wilhelm K, Mitchell P, Slade T, et al. Prevalence and correlates of DSM-IV major depression in an Australian national survey. J Affect Disord 2003 Jul; 75 (2):155-62 (Pubitemid 36645248)
7. Gili M, Garcia-Toro M, Vives M, et al. Medical comorbidity in recurrent versus first-episode depressive patients. Acta Psychiatr Scand 2011 Mar; 123 (3):220-7
8. Ryan J, Carriere I, Ritchie K, et al. Late-life depression and mortality: influence of gender and antidepressant use. Br J Psychiatry 2008 Jan; 192 (1):12-8 (Pubitemid 351183155)
9. Alexander JL, Dennerstein L, Kotz K, et al. Women, anxiety and mood: a review of nomenclature, comorbidity and epidemiology. Expert Rev Neurother 2007 Nov; 7 (11 Suppl.): S45-58
10. Sobocki P, Jonsson B, Angst J, et al. Cost of depression in Europe. J Ment Health Policy Econ 2006 Jun; 9 (2):87-98 (Pubitemid 44018376)
11. Lopez-Leon S, Janssens AC, Gonzalez-Zuloeta Ladd AM, et al. Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry 2008 Aug; 13 (8):772-85 (Pubitemid 352032108)
12. Ancelin ML, Scali J, Ritchie K. Hormonal therapy and depression: are we overlooking an important therapeutic alternative? J Psychosom Res 2007 Apr; 62 (4):473-85 (Pubitemid 46441264)
13. Osterlund MK. Underlying mechanisms mediating the antidepressant effects of estrogens. Biochim Biophys Acta 2010 Oct; 1800 (10):1136-44
14. Mokrani MC, Duval F, Crocq MA, et al. HPA axis dysfunction in depression: correlation with monoamine system abnormalities. Psychoneuroendocrinology 1997;22 Suppl. 1:S63-8 (Pubitemid 27380696)
15. Blier P. Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response. J Psychiatry Neurosci 2001;26 Suppl.: S3-10 (Pubitemid 34218788)
16. Meltzer HY. Role of serotonin in depression. Ann N Y Acad Sci 1990;600:486-99; discussion 99-500
17. Hirschfeld RM. History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry 2000;61 Suppl. 6:4-6 (Pubitemid 30217404)
18. Andrade TG, Nakamuta JS, Avanzi V, et al. Anxiolytic effect of estradiol in the median raphe nucleus mediated by 5-HT1A receptors. Behav Brain Res 2005 Aug. 30;163(1):18-25 (Pubitemid 40991717)
19. Matsuda T, Nakano Y, Kanda T, et al. Gonadal hormones affect the hypothermia induced by serotonin1A (5-HT1A) receptor activation. Life Sci 1991;48(17):1627-32
20. Summer BE, Fink G. Estrogen increases the density of 5-hydroxytryptamine (2A) receptors in cerebral cortex and nucleus accumbens in the female rat. J Steroid Biochem Mol Biol 1995 Jul; 54(1-2):15-20
21. Halbreich U, Borenstein J, Pearlstein T, et al. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder. Psychoneuroendocrinology 2003 Aug; 28 Suppl. 3:1-23 (Pubitemid 39658675)
22. Ryan J, Burger HG, Szoeke C, et al. A prospective study of the association between endogenous hormones and depressive symptoms in postmenopausal women. Menopause 2009 May-Jun; 16 (3):509-17
23. Soares CN, Zitek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability? J Psychiatry Neurosci 2008 Jul; 33 (4):331-43 (Pubitemid 351977159)
24. Ryan J, Carriere I, Scali J, et al. Lifetime hormonal factors may predict late-life depression in women. Int Psychogeriatr 2008 Dec; 20 (6):1203-18
25. Rapkin AJ. The role of serotonin in premenstrual syndrome. Clin Obstet Gynecol 1992 Sep; 35 (3):629-36
26. Cohen LS, Soares CN, Vitonis AF, et al. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 2006 Apr; 63 (4):385-90
27. Freeman EW, Sammel MD, Lin H, et al. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006 Apr; 63 (4):375-82
28. Bromberger JT, Matthews KA, Schott LL, et al. Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN). J Affect Disord 2007 Nov; 103(1-3):267-72 (Pubitemid 47445776)
29. Freeman EW. Associations of depression with the transition to menopause. Menopause 2010 Jul; 17 (4):823-7
30. Zweifel JE, O'Brien WH. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 1997;22(3):189-212 (Pubitemid 27293623)
31. Cohen LS, Soares CN, Poitras JR, et al. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. Am J Psychiatry 2003;160(8):1519-22 (Pubitemid 41070931)
32. Scali J, Ryan J, Carriere I, et al. A prospective study on hormonal treatment and depression in communitydwelling elderly women (The Three City Study). J Clin Psychiatry 2010 Dec; 71 (12):1673-9
33. Heldring N, Pike A, Andersson S, et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev 2007 Jul; 87 (3):905-31 (Pubitemid 47084672)
34. Osterlund MK, Hurd YL. Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog Neurobiol 2001;64(3):251-67 (Pubitemid 32194454)
35. Ostlund H, Keller E, Hurd YL. Estrogen receptor gene expression in relation to neuropsychiatric disorders. Ann N Y Acad Sci 2003 Dec; 1007:54-63 (Pubitemid 38258338)
36. Kuiper GG, Enmark E, Pelto-Huikko M, et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996 Jun. 11;93(12):5925-30 (Pubitemid 26190778)
37. Perlman WR, Webster MJ, Kleinman JE, et al. Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness. Biol Psychiatry 2004 Dec. 1;56(11):844-52 (Pubitemid 39575458)
38. Wissink S, Van der Burg B, Katzenellenbogen BS, et al. Synergistic activation of the serotonin-1A receptor by nuclear factor-kappa B and estrogen. Mol Endocrinol 2001 Apr; 15 (4):543-52 (Pubitemid 32328129)
39. Walf AA, Frye CA. Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacol Biochem Behav 2007 Feb; 86 (2):407-14 (Pubitemid 46282041)
40. Rocha BA, Fleischer R, Schaeffer JM, et al. 17 Betaestradiolinduced antidepressant-like effect in the forced swim test is absent in estrogen receptor-beta knockout (BERKO) mice. Psychopharmacology (Berl) (Berl) 2005 May; 179 (3):637-43 (Pubitemid 40674765)
41. Nilsson S, Makela S, Treuter E, et al. Mechanisms of estrogen action. Physiol Rev 2001 Oct; 81 (4):1535-65 (Pubitemid 32951806)
42. McEwen BS, Alves SE, Bulloch K, et al. Ovarian steroids and the brain: implications for cognition and aging. Neurology 1997 May; 48 (5 Suppl. 7): S8-15 (Pubitemid 27230087)
43. Katzenellenbogen BS. Dynamics of steroid hormone receptor action. Annu Rev Physiol 1980;42:17-35 (Pubitemid 10081238)
44. Brann DW, Dhandapani K, Wakade C, et al. Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids 2007 May; 72 (5):381-405 (Pubitemid 46602478)
45. Matthews J, Wihlen B, Tujague M, et al. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun. to estrogen-responsive promoters. Mol Endocrinol 2006 Mar; 20 (3):534-43 (Pubitemid 43292585)
46. Pettersson K, Delaunay F, Gustafsson JA. Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene 2000 Oct. 12;19(43):4970-8
47. Liu MM, Albanese C, Anderson CM, et al. Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J Biol Chem 2002 Jul. 5;277(27):24353-60 (Pubitemid 34951956)
48. Pace P, Taylor J, Suntharalingam S, et al. Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha. J Biol Chem 1997 Oct. 10;272(41):25832-8 (Pubitemid 27438906)
49. Almeida S, Hutz MH. Genetic variation of estrogen metabolism and the risks of cardiovascular disease. Curr Opin Investig Drugs 2007 Oct; 8 (10):814-20 (Pubitemid 47511878)
50. Ryan J, Canonico M, Carcaillon L, et al. Hormone treatment, estrogen receptor polymorphisms and mortality: a prospective cohort study. PLoS ONE 2012;7(3):e34112
51. Silvestri S, Thomsen AB, Gozzini A, et al. Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy? Menopause 2006 May-Jun; 13 (3):451-61
52. Herrington DM, Howard TD, Brosnihan KB, et al. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 2002 Apr. 23;105(16):1879-82 (Pubitemid 34437611)
53. Maruyama H, Toji H, Harrington CR, et al. Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer disease. Arch Neurol 2000;57(2):236-40 (Pubitemid 30097192)
54. Greendale GA, Chu J, Ferrell R, et al. The association of bone mineral density with estrogen receptor gene polymorphisms. Am J Med 2006 Sep; 119 (9 Suppl. 1): S79-86 (Pubitemid 44292106)
55. Kobayashi N, Fujino T, Shirogane T, et al. Estrogen receptor alpha polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen. Maturitas 2002 Mar. 25;41(3):193-201 (Pubitemid 34211974)
56. Malacara JM, Perez-Luque EL, Martinez-Garza S, et al. The relationship of estrogen receptor-alpha polymorphism with symptoms and other characteristics in postmenopausal women. Maturitas 2004 Oct. 15;49(2):163-9 (Pubitemid 39330429)
57. Weel AE, Uitterlinden AG, Westendorp IC, et al. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab 1999 Sep; 84 (9):3146-50 (Pubitemid 30646935)
58. Kjaergaard AD, Ellervik C, Tybjaerg-Hansen A, et al. Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis. Circulation 2007 Feb. 20;115(7):861-71 (Pubitemid 46294727)
59. Alevizaki M, Saltiki K, Cimponeriu A, et al. Severity of cardiovascular disease in postmenopausal women: associations with common estrogen receptor alpha polymorphic variants. Eur J Endocrinol 2007 Apr; 156 (4):489-96 (Pubitemid 46672651)
60. Shearman AM, Cooper JA, Kotwinski PJ, et al. Estrogen receptor alpha gene variation and the risk of stroke. Stroke 2005 Oct; 36 (10):2281-2 (Pubitemid 41429261)
61. Boada M, Antunez C, Lopez-Arrieta J, et al. Estrogen receptor alpha gene variants are associated with Alzheimer's disease. Neurobiol Aging 2012 Jan; 33 (1):198.e15-24
62. Becherini L, Gennari L, Masi L, et al. Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet 2000 Aug. 12;9(13):2043-50 (Pubitemid 30642669)
63. Del Senno L, Aguiari GL, Piva R. Dinucleotide repeat polymorphism in the human estrogen receptor (ESR) gene. Hum Mol Genet 1992 Aug; 1 (5):354
64. Yim CH, Choi JT, Choi HA, et al. Association of estrogen receptor alpha gene microsatellite polymorphism with annual changes in bone mineral density in Korean women with hormone replacement therapy. J Bone Miner Metab 2005;23(5):395-400 (Pubitemid 41223803)
65. Kunnas TA, Laippala P, Penttila A, et al. Association of polymorphism of human alpha oestrogen receptor gene with coronary artery disease in men: a necropsy study. BMJ 2000 Jul. 29;321(7256):273-4 (Pubitemid 30487465)
66. Domingues-Montanari S, Subirana I, Tomas M, et al. Association between ESR2 genetic variants and risk of myocardial infarction. Clin Chem 2008 Jul; 54 (7):1183-9 (Pubitemid 352009695)
67. Giedraitis V, Kilander L, Degerman-Gunnarsson M, et al. Genetic analysis of Alzheimer's disease in the Uppsala Longitudinal Study of Adult Men. Dement Geriatr Cogn Disord 2009;27(1):59-68
68. Gold B, Kalush F, Bergeron J, et al. Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res 2004 Dec. 15;64(24):8891-900 (Pubitemid 39665494)
69. He LN, Xiong DH, Liu YJ, et al. Association study of the oestrogen signalling pathway genes in relation to age at natural menopause. J Genet 2007 Dec; 86 (3):269-76
70. Rexrode KM, Ridker PM, Hegener HH, et al. Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women. Clin Chem 2007 Oct; 53 (10):1749-56 (Pubitemid 47509667)
71. Sowers MR, Jannausch ML, McConnell DS, et al. Endogenous estradiol and its association with estrogen receptor gene polymorphisms. Am J Med 2006 Sep; 119 (9 Suppl. 1): S16-22 (Pubitemid 44292098)
72. Takeo C, Negishi E, Nakajima A, et al. Association of cytosineadenine repeat polymorphism of the estrogen receptorbeta gene with menopausal symptoms. Gend Med 2005 Jun; 2 (2):96-105 (Pubitemid 40867870)
73. Yaffe K, Lindquist K, Sen S, et al. Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC study. Neurobiol Aging 2009 Apr; 30 (4):607-14
74. Prichard Z, Jorm AF, Prior M, et al. Association of polymorphisms of the estrogen receptor gene with anxietyrelated traits in children and adolescents: a longitudinal study. Am J Med Genet 2002 Mar. 8;114(2):169-76 (Pubitemid 34160468)
75. Comings DE, Muhleman D, Johnson P, et al. Potential role of the estrogen receptor gene (ESR1) in anxiety. Mol Psychiatry 1999 Jul; 4 (4):374-7 (Pubitemid 29440578)
76. Kravitz HM, Janssen I, Lotrich FE, et al. Sex steroid hormone gene polymorphisms and depressive symptoms in women at midlife. Am J Med 2006 Sep; 119 (9 Suppl. 1): S87-93 (Pubitemid 44292105)
77. Zhou B, Sun X, Zhang M, et al. The symptomatology of climacteric syndrome: whether associated with the physical factors or psychological disorder in perimenopausal/postmenopausal patients with anxiety-depression disorder. Arch Gynecol Obstet 2012 May; 285 (5):1345-52
78. Tiemeier H, Schuit SC, Den Heijer T, et al. Estrogen receptor alpha gene polymorphisms and anxiety disorder in an elderly population. Mol Psychiatry 2005 Sep; 10 (9):806-7 (Pubitemid 43080112)
79. Yalamanchili V, Gallagher JC. Treatment with hormone therapy and calcitriol did not affect depression in older postmenopausal women: no interaction with estrogen and vitamin D receptor genotype polymorphisms. Menopause 2012 Jun; 19 (6):697-703
80. Mill J, Kiss E, Baji I, et al. Association study of the estrogen receptor alpha gene (ESR1) and childhood-onset mood disorders. Am J Med Genet B Neuropsychiatr Genet 2008 Oct. 5;147 B (7):1323-6
81. Geng YG, Su QR, Su LY, et al. Comparison of the polymorphisms of androgen receptor gene and estrogen alpha and beta gene between adolescent females with first-onset major depressive disorder and controls. Int J Neurosci 2007 Apr; 117 (4):539-47
82. Huo L, Straub RE, Roca C, et al. Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biol Psychiatry 2007 Oct. 15;62(8):925-33 (Pubitemid 47496149)
83. Kishi T, Ikeda M, Kitajima T, et al. Association analysis of functional polymorphism in estrogen receptor alpha gene with schizophrenia and mood disorders in the Japanese population. Psychiatr Genet 2009 Aug; 19 (4):217-8
84. Tsai SJ, Wang YC, Hong CJ, et al. Association study of oestrogen receptor alpha gene polymorphism and suicidal behaviours in major depressive disorder. Psychiatr Genet 2003 Mar; 13 (1):19-22
85. Kim JJ, Pae CU, Kim MR, et al. Association between estrogen receptor gene polymorphisms and depression in post-menopausal women: a preliminary study. Psychiatry Investig 2010 Sep; 7 (3):224-7
86. Ryan J, Scali J, Carriere I, et al. Oestrogen receptor polymorphisms and late-life depression. Br J Psychiatry 2011 Aug; 199:126-31
87. Ryan J, Scali J, Carriere I, et al. Estrogen receptor alpha gene variants and major depressive episodes. J Affect Disord 2012 Feb; 136 (3):1222-6
88. Jones I, Middle F, McCandless F, et al. Molecular genetic studies of bipolar disorder and puerperal psychosis at two polymorphisms in the estrogen receptor alpha gene (ESR 1). Am J Med Genet 2000 Dec. 4;96(6):850-3
89. Feng J, Yan J, Michaud S, et al. Scanning of estrogen receptor alpha (ERalpha) and thyroid hormone receptor alpha (TRalpha) genes in patients with psychiatric diseases: four missense mutations identified in ERalpha gene. Am J Med Genet 2001 May 8;105(4):369-74 (Pubitemid 32578236)
90. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition. Washington, DC: American Psychiatric Association, 1994
91. Ryan J, Scali J, Carriere I, et al. Estrogen receptor gene variants are associated with anxiety disorders in older women. Psychoneuroendocrinology 2011 Nov; 36 (10):1582-6
92. Alonso P, Gratacos M, Segalas C, et al. Variants in estrogen receptor alpha gene are associated with phenotypical expression of obsessive-compulsive disorder. Psychoneuroendocrinology 2011 May; 36 (4):473-83
93. Lambert JC, Harris JM, Mann D, et al. Are the estrogen receptors involved in Alzheimer's disease? Neurosci Lett 2001;306(3):193-7 (Pubitemid 32530832)
94. Gillies GE, McArthur S. Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev 2010 Jun; 62 (2):155-98
95. Shen LX, Basilion JP, Stanton VP, et al. Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc Natl Acad Sci U S A 1999 Jul. 6;96(14):7871-6 (Pubitemid 29328374)
96. Duan J, Wainwright MS, Comeron JM, et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003 Feb. 1;12(3):205-16 (Pubitemid 36204418)
97. Aronow B, Lattier D, Silbiger R, et al. Evidence for a complex regulatory array in the first intron of the human adenosine deaminase gene. Genes Dev 1989 Sep; 3 (9):1384-400
98. Schuit SC, De Jong FH, Stolk L, et al. Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women. Eur J Endocrinol 2005 Aug; 153 (2):327-34 (Pubitemid 41167491)
99. Yaffe K, Lui LY, Grady D, et al. Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women. Biol Psychiatry 2002;51(8):677-82 (Pubitemid 34310505)
100. Gennari L, De Paola V, Merlotti D, et al. Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review. Expert Opin Pharmacother 2007 Apr; 8 (5):537-53 (Pubitemid 46547009)
101. Sundermann EE, Maki PM, Bishop JR. A review of estrogen receptor alpha gene (ESR1) polymorphisms, mood, and cognition. Menopause 2010 Jul; 17 (4):874-86
102. Perlman WR, Tomaskovic-Crook E, Montague DM, et al. Alteration in estrogen receptor alpha mRNA levels in frontal cortex and hippocampus of patients with major mental illness. Biol Psychiatry 2005 Nov. 15;58(10):812-24 (Pubitemid 41677420)
103. Gennari L, Merlotti D, De Paola V, et al. Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am J Epidemiol 2005 Feb. 15;161(4):307-20 (Pubitemid 40256202)
104. Nilsson S, Gustafsson JA. Estrogen receptors: therapies targeted to receptor subtypes. Clin Pharmacol Ther 2011 Jan; 89 (1):44-55
105. Zhao L, O'Neill K, Diaz Brinton R. Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs. Brain Res Brain Res Rev 2005 Nov; 49 (3):472-93 (Pubitemid 41546655)
106. Ongphiphadhanakul B, Chanprasertyothin S, Payatikul P, et al. Oestrogen-receptor-alpha gene polymorphism affects response in bone mineral density to oestrogen in post-menopausal women. Clin Endocrinol (Oxf) 2000 May; 52 (5):581-5 (Pubitemid 30337083)
107. Abbas S, Brauch H, Chang-Claude J, et al. Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy. Int J Cancer 2010 Jun. 15;126(12):2935-46
108. Herrington DM, Howard TD, Hawkins GA, et al. Estrogenreceptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 2002;346(13):967-74 (Pubitemid 34983246)
109. Van Duijnhoven FJ, Peeters PH, Warren RM, et al. Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic density. Cancer Epidemiol Biomarkers Prev 2006 Mar; 15 (3):462-7
110. Nemeroff CB. Prevalence and management of treatmentresistant depression. J Clin Psychiatry 2007;68 Suppl. 8:17-25
111. Cassano P, Soares CN, Cusin C, et al. Antidepressant response and well-being in pre-, peri-and postmenopausal women with major depressive disorder treated with fluoxetine. Psychother Psychosom 2005;74(6):362-5 (Pubitemid 41507285)
112. Kornstein SG, Schatzberg AF, Thase ME, et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 2000;157(9):1445-52
113. Archer JS. NAMS/Solvay Resident Essay Award. Relationship between estrogen, serotonin, and depression. Menopause 1999;6(1):71-8
114. Schmidt PJ, Nieman L, Danaceau MA, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 2000;183(2):414-20 (Pubitemid 30651090)
115. Soares CN, Almeida OP, Joffe H, et al. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebocontrolled trial. Arch Gen Psychiatry 2001;58(6):529-34 (Pubitemid 32523731)
116. Soares CN, Arsenio H, Joffe H, et al. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri-and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. Menopause 2006 Sep-Oct; 13 (5):780-6 (Pubitemid 44435032)
117. Soares CN, Poitras JR, Prouty J, et al. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms. J Clin Psychiatry 2003 Apr; 64 (4):473-9(Pubitemid 36547294)